Charles River Laboratories International, Inc.
CRL · NYSE
9/27/2025 | 6/28/2025 | 3/29/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | – | $7,372,841 | $7,882,807 | $9,440,075 |
| - Cash | $207,670 | $182,824 | $229,356 | $194,606 |
| + Debt | $2,628,638 | $2,786,038 | $2,985,865 | $2,723,994 |
| Enterprise Value | – | $9,976,055 | $10,639,316 | $11,969,463 |
| Revenue | $1,004,852 | $1,032,135 | $984,168 | $1,002,549 |
| % Growth | -2.6% | 4.9% | -1.8% | – |
| Gross Profit | $338,792 | $357,067 | $317,732 | $284,244 |
| % Margin | 33.7% | 34.6% | 32.3% | 28.4% |
| EBITDA | $197,767 | $220,892 | $184,226 | -$86,453 |
| % Margin | 19.7% | 21.4% | 18.7% | -8.6% |
| Net Income | $54,422 | $52,326 | $25,469 | -$215,699 |
| % Margin | 5.4% | 5.1% | 2.6% | -21.5% |
| EPS Diluted | 1.1 | 1.06 | 0.5 | -4.22 |
| % Growth | 3.8% | 112% | 111.8% | – |
| Operating Cash Flow | $213,826 | $204,603 | $171,697 | $159,362 |
| Capital Expenditures | -$35,580 | -$35,298 | -$59,324 | -$75,616 |
| Free Cash Flow | $178,246 | $169,305 | $112,373 | $83,746 |